RUNCORN, United Kingdom– Epredia, a global leader in precision cancer diagnostics, announced that its E1000 Dx Digital Pathology Solution won three categories in the 2025 International Scanner Benchmark (ISB) awards, presented by the Ecosystem for Pathology Diagnostics with AI Assistance (EMPAIA). The ISB program recognizes excellence in the quality, throughput, and design of digital slide scanning technology for pathology, and the awards were presented at the 37th European Congress of Pathology in Vienna, Austria.
The E1000 Dx is a high-speed, automated whole-slide imaging digital scanner paired with advanced image management and viewing software. Capable of generating high-resolution digital images of up to 1,500 tissue samples daily, the system is designed to increase laboratory efficiency through innovations in sample detection and quality control. EMPAIA noted that the E1000 Dx earned top honors in the Quality category for its 20x magnification objective, with pathologists reviewing images at 40x magnification, the highest tested level.
Epredia’s platform builds on technology developed by 3DHISTECH, a leading diagnostics company and close partner of Epredia. 3DHISTECH also received ISB recognition for its Pannoramic 480 Dx digital slide scanner in the High Throughput and Technical capabilities categories. Epredia distributes the full 3DHISTECH digital pathology portfolio, including the Pannoramic 480 Dx.
“Digital pathology is the future of cancer diagnostics,” said Steven Lynum, president of Epredia. “As pathology laboratories face greater pressure to speed up processes and reduce costs, we are deeply honored that EMPAIA has recognized the E1000 Dx as a leader in both high throughput and quality. AI holds tremendous potential to enhance the way conditions like cancer are diagnosed and treated, but AI is only as powerful as the images available to analyze. We look forward to Epredia and 3DHISTECH solutions helping laboratories maximize their digital pathology investment today, while supporting AI-powered diagnostics in the future.”
